SCHEMBL26645301

SCHEMBL26645301

CC(C)(C)OC(=O)N1CCn2nc(Br)c(-c3ccncc3)c2C1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CSNK1D P48730 2/20 0.44
▸ CSNK1E P49674 2/20 0.44
▸ GPR119 Q8TDV5 5/20 0.43
▸ USP30 Q70CQ3 1/20 0.41
▸ MAPK1 P28482 1/20 0.39
▸ NR1H2 P55055 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ CKS1B P61024 1/20 0.38
▸ SKP1 P63208 1/20 0.38
▸ SKP2 Q13309 1/20 0.38
▸ ESR2 Q92731 1/20 0.37
▸ PRKCI P41743 1/20 0.37
▸ GBA1 P04062 1/20 0.37
▸ GRM1 Q13255 1/20 0.37
▸ PDE10A Q9Y233 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26645317 0.85 CSNK1D (0.38) CSNK1DCSNK1EGPR119CKS1BSKP1
SCHEMBL30622970 0.85 CSNK1D (0.38) CSNK1DCSNK1EGPR119CKS1BSKP1
SCHEMBL26645466 0.85 CSNK1D (0.49) CSNK1DCSNK1EGPR119USP30MAPK1
SCHEMBL26645146 0.85 CSNK1D (0.39) CSNK1DCSNK1EUSP30NR1H2POLB
SCHEMBL17129177 0.84 CSNK1D (0.51) CSNK1DCSNK1EGPR119USP30MAPK1
SCHEMBL26645108 0.84 GPR119 (0.43) CSNK1DCSNK1EGPR119MAPK1NR1H2
SCHEMBL26645250 0.83 CSNK1D (0.48) CSNK1DCSNK1EGPR119USP30MAPK1
SCHEMBL26645074 0.82 CSNK1E (0.42) CSNK1DCSNK1EMAPK1ALDH1A1
SCHEMBL26645019 0.82 CSNK1D (0.47) CSNK1DCSNK1EGPR119POLBCKS1B
SCHEMBL26645681 0.82 CSNK1E (0.48) CSNK1DCSNK1EGPR119CKS1BSKP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4519265-A1 IRREVERSIBLE MUTEGFR INHIBITORS Bayer Aktiengesellschaft (DE) 2025-03-12 — — EP disclosed
WO-2023213882-A1 IRREVERSIBLE MUTEGFR INHIBITORS BAYER AKTIENGESELLSCHAFT (DE) 2023-11-09 — — WO disclosed
Send feedback